» Articles » PMID: 21796705

Pycnogenol® Inhibits Lipid Accumulation in 3T3-L1 Adipocytes with the Modulation of Reactive Oxygen Species (ROS) Production Associated with Antioxidant Enzyme Responses

Overview
Journal Phytother Res
Publisher Wiley
Date 2011 Jul 29
PMID 21796705
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Pycnogenol® is a group of flavonoids with antioxidant effects. Adipogenesis is the process of adipocyte differentiation. It causes the increase of lipids as well as ROS (reactive oxygen species). Lipid accumulation and ROS production were determined in 3 T3-L1 adipocyte, and the effect of Pycnogenol® was evaluated. Lipid accumulation was elevated in adipocyte treated with hydrogen peroxide, one of the ROS. Pycnogenol® showed an inhibitory effect on the lipid accumulation and ROS production during the adipogenesis. We also investigated the molecular events associated with ROS production and lipid accumulation. Our results showed that Pycnogenol® inhibited the mRNA expression of pro-oxidant enzymes, such as NOX4 (NADPH (nicotinamide adenine dinucleotide phosphate hydrogen) oxidase 4), and the NADPH-producing G6PDH (glucose-6-phosphate dehydrogenase) enzyme. In addition, Pycnogenol® suppressed the mRNA abundance of adipogenic transcription factors, PPAR-γ (peroxisome proliferator-activated receptor γ) and C/EBP-α (CCAAT/enhancer binding protein α), and their target gene, aP2 (adipocyte protein 2) responsible for fatty acid transportation. On the other hand, Pycnogenol® increased the abundance of antioxidant proteins such as Cu/Zn-SOD (copper-zinc superoxide dismutase), Mn-SOD (manganese superoxide dismutase), GPx (glutathione peroxidase) and GR (glutathione reductase). Our results suggest that Pycnogenol® inhibits lipid accumulation and ROS production by regulating adipogenic gene expression and pro-/antioxidant enzyme responses in adipocytes.

Citing Articles

Reduction of NADPH oxidase 4 in adipocytes contributes to the anti-obesity effect of dihydroartemisinin.

Hua H, Wu M, Wu T, Ji Y, Jin L, Du Y Heliyon. 2023; 9(3):e14028.

PMID: 36915539 PMC: 10006843. DOI: 10.1016/j.heliyon.2023.e14028.


Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation.

Liu Z, Zhu F, Zhang P, Qian B, Liu W, Xiao Y Front Genet. 2022; 13:1074981.

PMID: 36506302 PMC: 9728801. DOI: 10.3389/fgene.2022.1074981.


Leuconostoc mesenteroides utilizes glucose fermentation to produce electricity and ameliorates high-fat diet-induced abdominal fat mass.

Pham M, Tran T, Zayabaatar E Arch Microbiol. 2022; 204(11):670.

PMID: 36241916 DOI: 10.1007/s00203-022-03281-2.


The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.

Qorbani M, Sanginabadi M, Mohajeri-Tehrani M, Karimi S, Gerami H, Mahdavi-Gorabi A Front Endocrinol (Lausanne). 2021; 11:590392.

PMID: 33408691 PMC: 7779998. DOI: 10.3389/fendo.2020.590392.


Leuconostoc mesenteroides mediates an electrogenic pathway to attenuate the accumulation of abdominal fat mass induced by high fat diet.

Pham M, Yang J, Balasubramaniam A, Rahim A, Adi P, Do T Sci Rep. 2020; 10(1):21916.

PMID: 33318546 PMC: 7736347. DOI: 10.1038/s41598-020-78835-9.